The ins and outs of HIV replication

Cellular Microbiology

Volumn 7, Issue 5, 2005, Pages 621-626

  Gomez, Candace ^a   Hope, Thomas J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL PROTEIN; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; CELL MEMBRANE; EUKARYOTIC CELLS; GENOME, VIRAL; HIV-1; HUMANS; REVERSE TRANSCRIPTION; VIRUS REPLICATION;

EID: 17844392654     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2005.00516.x     Document Type: Short Survey

References (46)

1. Alroy, I., Tuvia, S., Greener, T., Gordon, D., Barr, H.M., Taglicht, D., et al. (2005) The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. Proc Natl Acad Sci USA 102: 1478-1483.
2. Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., et al. (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 96: 5698-5703.
3. Bieniasz, P.D. (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5: 1109-1115.
4. Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S., and Landau, N.R. (1997) Change in coreceptor use coreceptor use correlates with disease progression in HIV-1 - infected individuals. J Exp Med 185: 621-628.
5. Derdowski, A., Ding, L., and Spearman, P. (2004) A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. J Virol 78: 1230-1242.
6. Doms, R.W. (2000) Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276: 229-237.
7. Donzella, G.A., Schols, D., Lin, S.W., Este, J.A., Nagashima, K.A., Maddon, P.J., et al. (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 4: 72-77.
8. Fevrier, B., and Raposo, G. (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16: 415-421.
9. Freed, E.O. (2002) Viral late domains. J Virol 76: 4679-4687.
10. Garrus, J.E., U.K. von Schwedler, O.W., Pornillos, S.G., Morham, K.H., Zavitz, H.E., Wang, D.A., et al. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65.
11. Gould, S.J., Booth, A.M., and Hildreth, J.E. (2003) The Trojan exosome hypothesis. Proc Natl Acad Sci USA 100: 10592-10597.
12. Greenberg, M., Cammack, N., Salgo, M., and Smiley, L. (2004) HIV fusion and its inhibition in antiretroviral therapy. Rev Med Virol 14: 321-337.
13. Ichiyama, K.S., Yokoyama-Kumakura, Y., Tanaka, R., Tanaka, K., et al. (2003) A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 100: 4185-4190.
14. Jablonowski, H. (2003) Antiretroviral therapy 2003. The current status. MMW Fortschr Med 145(Spec No 1): 4-8.
15. Jamjian, M.C., and McNicholl, I.R. (2004) Enfuvirtide: first fusion inhibitor for treatment of HIV infection. Am J Health Syst Pharm 61: 1242-1247.
16. Jolly, C., Kashefi, K., Hollinshead, M., and Sattentau, Q.J. (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199: 283-293.
17. Kuhmann, S.E., Platt, E.J., Kozak, S.L., and Kabat, D. (2000) Cooperation of multiple CCR5 coreceptors; is required for infections by human immunodeficiency virus type 1. J Virol 74: 7005-7015.
18. Lederman, M.M., Veazey, R.S., Offord, R., Mosier, D.E., Dufour, J., Mefford, M., et al. (2004) Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306: 485-487.
19. Lin, Y.L., Mettling, C., Portales, P., Reynes, J., Clot, J., and Corbeau, P. (2002) Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc Natl Acad Sci USA 99: 15590-15595.
20. Lippincott-Schwartz, J., and Patterson, G.H. (2003) Development and use of fluorescent protein markers in living cells. Science 300: 87-91.
21. Lu, M., Blacklow, S.C., and Kim, P.S. (1995) A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 2: 1075-1082.
22. McCune, J.M., Rabin, L.B., Feinberg, M.B., Lieberman, M., Kosek, J.C., Reyes, G.R., and Weissman, I.L. (1988) Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53: 55-67.
23. McDonald, D., Vodicka, M.A., Lucero, G., Svitkina, T.M., Borisy, G.G., Emerman, M., and Hope, T.J. (2002) Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159: 441-452.
24. McDonald, D., Wu, L., Bohks, S.M., Kewa, V.N., Ramani, I., Unutmaz, D., and Hope, T.J. (2003) Recruitment of HIV and its receptors to dendritic cell - T cell junctions. Science 300: 1295-1297.
25. Marechal, V., Prevost, M.C., Petit, C., Perret, E., Heard, J.M., and Schwartz, O. (2001) Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75: 11166-11177.
26. Markosyan, R.M., Cohen, F.S., and Melikyan, G.B. (2003) HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol Biol Cell 14: 926-938.
27. Melikyan, G.B., Markosyan, R.M., Hemmati, H., Delmedico, M.K., Lambert, D.M., and Cohen, F.S. (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 151: 413-423.
28. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., et al. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638.
29. Nguyen, D.H., and Hildreth, J.E. (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74: 3264-3272.
30. Nguyen, G.T., Carrington, M., Beeler, J.A., Dean, M., Aledort, L.M., Blatt, P.M., et al. (1999) Phenotypic expressions of CCR5-delta32/delta32 homozygosity. J Acquir Immune Defic Syndr 22: 75-82.
31. Pearce-Pratt, R., Malamud, D., and Phillips, D.M. (1994) Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J Virol 68: 2898-2905.
32. Pelchen-Matthews, A., Kramer, B., and Marsh, M. (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162: 443-455.
33. Perotti, M.E., Tan, X., and Phillips, D.M. (1996) Directional budding of human immunodeficiency virus from monocytes. J Virol 70: 5916-5921.
34. Raiborg, C., Rusten, T.E., and Stenmark, H. (2003) Protein sorting into multivesicular endosomes. Curr Opin Cell Biol 15: 446-455.
35. Raposo, G., Moore, M., Innes, D., Leijendekker, R., Leigh-Brown, A., Benaroch, P., and Geuze, H. (2002) Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3: 718-729.
36. Rose, K.M., Marin, M., Kozak, S.L., and Kabat, D. (2004) The viral infectivity factor (Vif) of HIV-1 unveiled. Trends Mol Med 10: 291-297.
37. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
38. Sandefur, S., Smith, R.M., Varthakavi, V., and Spearman, P. (2000) Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55 (Gag). J Virol 74: 7238-7249.
39. Schramm, B., Penn, M.L., Speck, R.F., Chan, S.Y., De Clercq, E., Schols, D., et al. (2000) Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. J Virol 74: 184-192.
40. Scozzafava, A., Mastrolorenzo, A., and Supuran, C.T. (2002) Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents. J Enzyme Inhib Med Chem 17: 69-76.
41. Simmons, G., Wilkinson, D., Reeves, J.D., Dittmar, M.T., Beddows, S., Weber, J., et al. (1996) Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70: 8355-8360.
42. Steffens, C.M., and Hope, T.J. (2003) Localization of CD4 and CCR5 in living cells. J Virol 77: 4985-4991.
43. Steffens, C.M., and Hope, T.J. (2004) Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol 78: 9573-9578.
44. Strack, B., Calistri, A., Craig, S., Popova, E., and Gottlinger, H.G. (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114: 689-699.
45. Strizki, J.M., Xu, S., Wagner, N.E., Wojcik, L., Liu, J., Hou, Y., et al. (2001) SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci USA 98: 12718-12723.
46. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., and Littman, D.R. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-599.